Question from a patient
Fred Mamuya, MD, MPH
Constantly in the news, swine ﬂu (H1N1) can be confusing and frightening.
Question:What is swine ﬂu?Answer:
The World Health Organization (WHO) hasdesignated the 2009 pandemic inﬂuenza (H1N1) as the“Swine ﬂu.”
Question:If I am a cardiac patient, what should I do?Answer:
You should receive the regular annual inﬂuenzavaccine and the newly approved swine ﬂu vaccine. If youare over 65 years of age, you should also make sure thatyou are up to date with your pneumonia vaccination.
Question:What symptoms should I be concerned about?Answer:
Shortness of breath with activity or at rest, highfever that persists more than 3 days, rapid or shallow
breathing, turning blue, bloody or colored phlegm, chestpain, low blood pressure, decreased activity,lightheadedness, decreased urination, lethargy,drowsiness, diﬃculty awakening, confusion, severeweakness, or paralysis are some common concerningsymptoms. However, if you do not feel well, please callyour physician before more serious symptoms develop.
Question:What is the recommended treatment forswine-ﬂu (H1N1)?Answer:
Oseltamivir (Tamiﬂu) started within 48 hours ofonset of symptoms is the recommended treatment. IfTamiﬂu is unavailable, treatment with Relanza (zanamivir)should be considered. Treatment should be started asearly as possible, and laboratory conﬁrmation of inﬂuenzavirus infection is not necessary prior to initiation oftreatment. Thus, please remember to call your primarycare physician with any concerning symptoms.
Updates on H1N1 are available at the US Department of Healthand Human Services website: www.ﬂu.gov.
ProCor plays leading role in international CVD training summit
"Am health worker, I need your help, I need freeOxford handbook on medicine. I hope you helpme in this way. My address in Algeria...." Message from visitor to ProCor's website, Oct. 2009
Access to the global knowledge-base is fundamental torecruiting, educating, developing, and retaining peoplewho can play a role in cardiovascular disease prevention--from village health workers to cardiologists.ProCor recently helped organize a two-day internationalsummit focused on developing new strategies for training a global workforce to prevent CVD. Seventypeople from 20 countries attended the Global Summit onEducation and Training in Heart Disease and StrokePrevention at the US Centers for Disease Control andPrevention in Atlanta on October 14-16, 2009.Dr. Brian Bilchik, ProCor’s Director, is Co-chair of theRegional and Global Collaboration ImplementationGroup of the National Forum for Heart and StrokePrevention, which sponsored the summit. CatherineColeman, Editor in Chief, ProCor, and Dr. Vikas Saini,Foundation President, also participated.To guide the planning of the Summit, a survey of globalCVD training needs was emailed to ProCor’s 1300-member network and to members of the NationalForum. Based on survey results, plenary sessionsexplored diverse trainingformats, such as short courses,fellowships, and continuingeducation. Dr. Bilchik andCatherine Coleman deliveredpresentations on OnlineLearning that highlightedProCor and other programsthat use technology to supportCVD training and education.Small-group “brainstorming”sessions explored potentialways of meeting the training needs of clinicians, healthprofessionals, researchers, and policymakers. Dr. Sainimoderated a session on the training and education needsof clinicians.In the ﬁnal plenary session, participants were asked tocollectively describe an “ideal” long-term strategy todevelop and sustain a national CVD prevention workforce,after which Dr. Billy Bosu, Director of NoncommunicableDiseases, Ministry of Health, Ghana, was asked to providea reality check. “Other things will be required as well---likepolitical will and funding for chronic disease prevention,”he observed. “We need to be aware of the challenges, butnot daunted.”
Read more about global heart health at www.procor.org.
Dr. Brian Bilchik presented asession on Online Learning atthe Global Summit onEducation and Training inHeart Disease and StrokePrevention.